From: Predictors of progression of multiple sclerosis in a sample of Egyptian patients
RRMS (n = 150) | SPMS (n = 150) | p-value | |||
---|---|---|---|---|---|
No. | % | No. | % | ||
Female | 114 | 76 | 111 | 74 | 0.69 |
Smoking | 18 | 12 | 34 | 22.7 | 0.015* |
Comorbidities | 18 | 88 | 34 | 77.3 | 0.015* |
DM | 6 | 4 | 17 | 11.3 | 0.028* |
DVT | 0 | 0 | 1 | 0.7 | 1 |
Epilepsy | 2 | 1.3 | 2 | 1.3 | 1 |
Favism | 0 | 0 | 1 | 0.7 | 1 |
HTN | 6 | 4 | 9 | 6 | 0.6 |
Hyperthyroidism | 0 | 0 | 1 | 0.7 | 1 |
Hypothyroidism | 4 | 2.7 | 2 | 1.3 | 0.68 |
Thyroiditis | 0 | 0 | 1 | 0.7 | 1 |
Vitamin D deficiency | 18 | 12 | 31 | 19.3 | 0.04* |
Age years, mean ± SD | 31.9 ± 6.48 | 33.08 ± 5.89 | 0.1 | ||
Onset age, mean ± SD | 27.4 ± 6.3 | 28.5 ± 5.36 | 0.1 | ||
Disease duration, mean ± SD | 4.52 ± 3.24 | 5.14 ± 1.48 | 0.034* | ||
Time before diagnosis, mean ± SD | 0.07 ± 0.01 | 0.32 ± 0.08 | < 0.001* | ||
BMI | 26.34 ± 4.72 | 28.18 ± 5.66 | 0.002 | ||
Educated | 135 | 90 | 138 | 92 | 0.545 |
Employed | 85 | 56.7 | 42 | 28 | < 0.001* |